Kress Jean-Paul

Director at Vor Biopharma Inc. · on record since Jun 27, 2025
CEO and Chairman at Vor Biopharma Inc. · on record since Jun 27, 2025
Director at Sarepta Therapeutics, Inc. · on record since Oct 8, 2015
EVP Pres Int'l & Global Hd GTO at BIOGEN INC. · on record since Jun 20, 2017

Insider trading activity of Kress Jean-Paul

Transactions on record: 9; since Oct 8, 2015

Open-market buys: 0

Open-market sells: 0

Companies traded: 3; last filing Dec 9, 2025

Figures computed from official regulatory filings — .

Companies where Kress Jean-Paul has traded

Vor Biopharma Inc.3 tx · Dec 9, 2025
BIOGEN INC.1 tx · Jul 5, 2017
Sarepta Therapeutics, Inc.5 tx · Mar 14, 2017

Track record of Kress Jean-Paul

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Kress Jean-Paul

Co-insiders of Kress Jean-Paul

Cumbo AlexanderSarepta Therapeutics, Inc. +1
Mahatme SandeshSarepta Therapeutics, Inc. +1
5AM Opportunities I (GP), LLCVor Biopharma Inc.
5AM Opportunities I, L.P.Vor Biopharma Inc.
5AM Partners VI, LLCVor Biopharma Inc.
5AM Ventures VI, L.P.Vor Biopharma Inc.
ADELMAN BURT ABIOGEN INC.
ALEXANDER SUSAN HBIOGEN INC.
Alexandria Venture Investments, LLCVor Biopharma Inc.
ANG ROBERTVor Biopharma Inc.
Aphale JayantSarepta Therapeutics, Inc.
Arif BilalSarepta Therapeutics, Inc.
Arner Raymond GBIOGEN INC.
Artavanis-Tsakonas SpyridonBIOGEN INC.
Attar Eyal C.Vor Biopharma Inc.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Value · USD	Src
Vor Biopharma Inc.Listing on record	Dec 9, 2025	AwardD (derivative)	4,164,831	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Vor Biopharma Inc.Listing on record	Dec 9, 2025	OtherD (derivative)	-4,164,831	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Vor Biopharma Inc.Listing on record	Jun 27, 2025	AwardD (derivative)	83,296,638	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
BIOGEN INC.Listing on record	Jul 5, 2017	AwardD (derivative)	4,660	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sarepta Therapeutics, Inc.Listing on record	Mar 14, 2017	Award	1,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sarepta Therapeutics, Inc.Listing on record	Mar 14, 2017	AwardD (derivative)	12,350	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sarepta Therapeutics, Inc.Listing on record	Mar 2, 2016	AwardD (derivative)	10,500	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sarepta Therapeutics, Inc.Listing on record	Mar 2, 2016	Award	1,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sarepta Therapeutics, Inc.Listing on record	Oct 8, 2015	AwardD (derivative)	7,692	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC

Company	Filed	Type	Qty	Value · USD	Src
Vor Biopharma Inc.Listing on record	Dec 9, 2025	AwardD (derivative)	4,164,831	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Vor Biopharma Inc.Listing on record	Dec 9, 2025	OtherD (derivative)	-4,164,831	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Vor Biopharma Inc.Listing on record	Jun 27, 2025	AwardD (derivative)	83,296,638	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
BIOGEN INC.Listing on record	Jul 5, 2017	AwardD (derivative)	4,660	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sarepta Therapeutics, Inc.Listing on record	Mar 14, 2017	Award	1,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sarepta Therapeutics, Inc.Listing on record	Mar 14, 2017	AwardD (derivative)	12,350	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sarepta Therapeutics, Inc.Listing on record	Mar 2, 2016	AwardD (derivative)	10,500	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sarepta Therapeutics, Inc.Listing on record	Mar 2, 2016	Award	1,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Sarepta Therapeutics, Inc.Listing on record	Oct 8, 2015	AwardD (derivative)	7,692	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC